-
|
Reuters –
6:13 AM ET 08/11/2022
West Pharmaceutical Services Inc (WST): * WEST MAKES MINORITY INVESTMENT IN DUBLIN-BASED LATCH MEDICAL, A DEVELOPER OF VACCINE AND BIOLOGICS DELIVERY PLATFORMS. * West Pharmaceutical Services Inc (WST) - WILL TAKE A MINORITY OWNERSHIP STAKE IN LATCH MEDICAL Source text for Eikon: Further company coverage:
|
-
|
PR Newswire –
6:00 AM ET 08/11/2022
EXTON, Pa., Aug. 11, 2022 West Pharmaceutical Services (WST), Inc., a global leader in innovative solutions for injectable drug administration, today announced it has made a strategic investment in Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a new approach to intradermal delivery.
|
-
|
Benzinga –
12:37 PM ET 08/05/2022
West Pharmaceutical Servs has outperformed the market over the past 10 years by 18.96% on an annualized basis producing an average annual return of 30.3%. Currently, West Pharmaceutical Servs has a market capitalization of $25.12 billion.
|
-
|
Benzinga –
9:53 AM ET 08/03/2022
According to Benzinga Pro, during Q2, West Pharmaceutical Servs earned $188.50 million, a 8.46% increase from the preceding quarter. Earnings data without context is not clear and can be difficult to base trading decisions on. It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool.
|
-
|
Benzinga –
4:40 PM ET 08/02/2022
West Pharmaceutical Servs's short percent of float has risen 6.5% since its last report. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock.
|
-
|
Benzinga –
7:13 AM ET 07/28/2022
West Pharmaceutical Servs reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement. West Pharmaceutical Servs beat estimated earnings by 11.76%, reporting an EPS of $2.47 versus an estimate of $2.21. Revenue was up $47.70 million from the same period last year.
|
-
|
Reuters –
6:08 AM ET 07/28/2022
West Pharmaceutical Services Inc (WST) : * WEST ANNOUNCES SECOND-QUARTER 2022 RESULTS. * Q2 ADJUSTED EARNINGS PER SHARE $2.47. * Q2 EARNINGS PER SHARE $2.48. * Q2 NET SALES OF $771.3 MILLION GREW 6.6%; ORGANIC NET SALES GROWTH WAS 13.1% * SEES FULL-YEAR 2022 NET SALES ARE EXPECTED TO BE IN THE RANGE OF $2.950 BILLION TO $2.975 BILLION.
|
-
|
Benzinga –
6:06 AM ET 07/28/2022
** ArcelorMittal is estimated to report earnings for its second quarter. ** argenx is likely to report quarterly loss at $4.83 per share on revenue of $37.85 million. ** ASE Technology Holding Co is estimated to report quarterly earnings at $0.20 per share on revenue of $5.08 billion. ** Barclays is estimated to report earnings for its second quarter.
|
-
|
PR Newswire –
6:00 AM ET 07/28/2022
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., July 28, 2022 /PRNewswire/ -- WEST PHARMACEUTICAL SERVICES, INC. (WST) today announced its financial results for the second-quarter 2022 and updated full-year 2022 financial guidance.
|
-
|
Benzinga –
5:06 AM ET 07/28/2022
** ArcelorMittal is estimated to report earnings for its second quarter. ** argenx is likely to report quarterly loss at $4.83 per share on revenue of $37.85 million. ** ASE Technology Holding Co is estimated to report quarterly earnings at $0.20 per share on revenue of $5.08 billion. ** Barclays is estimated to report earnings for its second quarter.
|
-
|
Reuters –
8:24 AM ET 07/27/2022
West Pharmaceutical Services Inc (WST) : * West Pharmaceutical Services Inc (WST) - BOARD NOW HAS 11 DIRECTORS Source: [ID: https://bit.ly/3owvqQg] Further company coverage:
|
-
|
Reuters –
6:27 AM ET 07/27/2022
West Pharmaceutical Services Inc (WST) : * WEST ELECTS NEW DIRECTOR TO THE BOARD Source text for Eikon: Further company coverage:
|
-
|
PR Newswire –
6:00 AM ET 07/27/2022
EXTON, Pa., July 27, 2022 West Pharmaceutical Services (WST), Inc. , a global leader in innovative solutions for injectable drug administration, announced today the Company's Board of Directors has elected Stephen Lockhart, M.D., Ph.D., as its newest member. Northern California. Serving in this role for over seven years, he was responsible for quality, patient safety, research and education.
|
-
|
PR Newswire –
5:00 PM ET 07/14/2022
EXTON, Pa., July 14, 2022 West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2022 financial results before the market opens on Thursday, July 28, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
|
-
|
PR Newswire –
3:00 PM ET 07/12/2022
EXTON, Pa., July 12, 2022 West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, has recently released its 2021 Corporate Responsibility Report, reporting on the Company's environmental, social, and governance performance in 2021.
|
-
|
PR Newswire –
6:00 AM ET 06/13/2022
EXTON, Pa., June 13, 2022 West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, today announced that it will unveil its new Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System at BIO International Convention, taking place in San Diego, CA from June 13-16, 2022.
|
-
|
PR Newswire –
4:30 PM ET 05/24/2022
The DeltaCube Modeling Platform is an analytics platform aimed at container closure system selection, optimization, and usage EXTON, Pa., May 24, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced it received the Biotech Innovation Award for the DeltaCube Modeling Platform at the INTERPHEX 2022 T...
|
-
|
PR Newswire –
4:30 PM ET 05/23/2022
West to present on industry trends, enabling technologies, packaging components, and innovative DeltaCube Modeling Platform EXTON, Pa., May 23, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at INTERPHEX 2022 to showcase its leadership and expertise on industry challenges and...
|
-
|
Benzinga –
11:15 AM ET 04/28/2022
West Pharmaceutical Services Shares Slides Post Q1 Results
|
Page:
|
Today's and Upcoming Events
-
WST to announce Q3 earnings (Unconfirmed)
Past Events (last 90 days)
-
WST announced Q2 earnings.
-
WST ex-Dividend for $0.18 on 07/19/2022
- Announce Date: 04/28/2022
- Record Date: 07/20/2022
- Pay Date: 08/03/2022
Data provided by Thomson Reuters © 2022
|